إعلان
إعلان
BTAI
BioXcel Therapeutics, Inc. Common Stock
2.00
USDبرعاية
-0.04
-1.76%
٠٨ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
2.00
-0.01
-0.45%
تقارير أرباح BTAI
النسبة الإيجابية المفاجئة
BTAI تفوق 14 من 31 آخر التقديرات.
45%
التقرير التالي
بيانات التقرير القادم
٢٥ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$178.50K
/-$0.83
التغير الضمني من Q3 25 (Revenue/ EPS)
+82.14%
/-61.93%
التغير الضمني من Q4 24 (Revenue/ EPS)
-51.23%
/-76.75%
BioXcel Therapeutics, Inc. Common Stock earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, BTAI reported earnings of -2.18 USD per share (EPS) for Q3 25, missing the estimate of -1.20 USD, resulting in a -81.50% surprise. Revenue reached 98.00 ألف, compared to an expected 216.75 ألف, with a -54.79% difference. The market reacted with a -15.35% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 المحللين forecast an EPS of -0.83 USD, with revenue projected to reach 178.50 ألف USD, implying an نقصان of -61.93% EPS, and زيادة of 82.14% in Revenue from the last quarter.
الأسئلة الشائعة
What were BioXcel Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, BioXcel Therapeutics, Inc. Common Stock reported EPS of -$2.18, missing estimates by -81.5%, and revenue of $98.00K, -54.79% below expectations.
How did the market react to BioXcel Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -15.35%, changed from $2.02 before the earnings release to $1.71 the day after.
When is BioXcel Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٥ مارس ٢٠٢٦.
What are the forecasts for BioXcel Therapeutics, Inc. Common Stock's next earnings report?
Based on 6
المحللين, BioXcel Therapeutics, Inc. Common Stock is expected to report EPS of -$0.83 and revenue of $178.50K for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان